• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

草药和活性成分在中医指导下改善非酒精性脂肪肝。

Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine.

机构信息

Department of Hepatology, ShuGuang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Department of Infection, Oriental Hospital Affiliated to Tongji University, Shanghai, China.

出版信息

Front Endocrinol (Lausanne). 2022 Sep 20;13:1000727. doi: 10.3389/fendo.2022.1000727. eCollection 2022.

DOI:10.3389/fendo.2022.1000727
PMID:36204095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9530134/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is a global health problem, and its prevalence has been on the rise in recent years. Traditional Chinese Medicine (TCM) contains a wealth of therapeutic resources and has been in use for thousands of years regarding the prevention of liver disease and has been shown to be effective in the treatment of NAFLD in China. but the molecular mechanisms behind it have not been elucidated. In this article, we have updated and summarized the research and evidence concerning herbs and their active ingredients for the treatment and models of NAFLD or NASH, by searching PubMed, Web of Science and SciFinder databases. In particular, we have found that most of the herbs and active ingredients reported so far have the effect of clearing heat and dispelling dampness, which is consistent with the concept of dampness-heat syndrome, in TCM theory. we have attempted to establish the TCM theory and modern pharmacological mechanisms links between herbs and monomers according to their TCM efficacy, experiment models, targets of modulation and amelioration of NAFLD pathology. Thus, we provide ideas and perspectives for further exploration of the pathogenesis of NAFLD and herbal therapy, helping to further the scientific connotation of TCM theories and promote the modernization of TCM.

摘要

非酒精性脂肪性肝病(NAFLD)是一个全球性的健康问题,近年来其患病率一直在上升。中医药(TCM)包含丰富的治疗资源,几千年来一直用于预防肝病,并已被证明在中国治疗非酒精性脂肪性肝病(NAFLD)有效。但其背后的分子机制尚未阐明。本文通过检索 PubMed、Web of Science 和 SciFinder 数据库,更新并总结了有关草药及其活性成分治疗和非酒精性脂肪性肝炎(NASH)模型的研究和证据。特别是,我们发现到目前为止,报道的大多数草药和活性成分都具有清热利湿的作用,这与中医理论中的湿热证概念一致。我们试图根据草药的中医功效、实验模型、调控和改善 NAFLD 病理的靶点,将草药和单体的中医理论和现代药理学机制联系起来。因此,我们为进一步探讨 NAFLD 的发病机制和草药治疗提供了思路和视角,有助于进一步丰富中医理论的科学内涵,促进中医现代化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c078/9530134/65fd8aa1f539/fendo-13-1000727-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c078/9530134/e1f8eb303eb8/fendo-13-1000727-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c078/9530134/1b250975c27c/fendo-13-1000727-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c078/9530134/12d949c58095/fendo-13-1000727-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c078/9530134/159d645a6853/fendo-13-1000727-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c078/9530134/e9c6ad60676e/fendo-13-1000727-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c078/9530134/65fd8aa1f539/fendo-13-1000727-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c078/9530134/e1f8eb303eb8/fendo-13-1000727-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c078/9530134/1b250975c27c/fendo-13-1000727-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c078/9530134/12d949c58095/fendo-13-1000727-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c078/9530134/159d645a6853/fendo-13-1000727-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c078/9530134/e9c6ad60676e/fendo-13-1000727-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c078/9530134/65fd8aa1f539/fendo-13-1000727-g006.jpg

相似文献

1
Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine.草药和活性成分在中医指导下改善非酒精性脂肪肝。
Front Endocrinol (Lausanne). 2022 Sep 20;13:1000727. doi: 10.3389/fendo.2022.1000727. eCollection 2022.
2
Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease.中药单体治疗非酒精性脂肪性肝病的研究进展。
Eur J Pharmacol. 2021 May 5;898:173976. doi: 10.1016/j.ejphar.2021.173976. Epub 2021 Feb 24.
3
Etiology Exploration of Non-alcoholic Fatty Liver Disease From Traditional Chinese Medicine Constitution Perspective: A Cross-Sectional Study.从中医体质角度探讨非酒精性脂肪性肝病的病因:一项横断面研究。
Front Public Health. 2021 May 12;9:635818. doi: 10.3389/fpubh.2021.635818. eCollection 2021.
4
Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives.中医在非酒精性脂肪性肝病中的应用:分子机制与治疗前景
Chin Med. 2021 Aug 3;16(1):68. doi: 10.1186/s13020-021-00469-4.
5
Treatment of neuropathic pain by traditional Chinese medicine: An updated review on their effect and putative mechanisms of action.中医药治疗神经性疼痛:作用及作用机制的更新评价。
Phytother Res. 2024 Jun;38(6):2962-2992. doi: 10.1002/ptr.8180. Epub 2024 Apr 10.
6
Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress.中草药:针对氧化应激的非酒精性脂肪肝疾病调节剂。
J Ethnopharmacol. 2024 Jan 10;318(Pt B):116927. doi: 10.1016/j.jep.2023.116927. Epub 2023 Jul 31.
7
The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine.从中医角度看帕金森病的发病机制及治疗机理。
Phytomedicine. 2022 Jun;100:154044. doi: 10.1016/j.phymed.2022.154044. Epub 2022 Mar 15.
8
Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.基于网络药理学分析和实验验证探讨降脂汤治疗非酒精性脂肪肝的分子机制。
Biomed Res Int. 2020 Dec 12;2020:8829346. doi: 10.1155/2020/8829346. eCollection 2020.
9
Research progress in the treatment of slow transit constipation by traditional Chinese medicine.中医药治疗慢传输型便秘的研究进展。
J Ethnopharmacol. 2022 May 23;290:115075. doi: 10.1016/j.jep.2022.115075. Epub 2022 Feb 5.
10
Advances in traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease.中医药治疗慢性阻塞性肺疾病的研究进展。
J Ethnopharmacol. 2023 May 10;307:116229. doi: 10.1016/j.jep.2023.116229. Epub 2023 Feb 9.

引用本文的文献

1
In silico and in vitro investigations reveal pan-PPAR agonist activity and anti-NAFLD efficacy of polydatin by modulating hepatic lipid-energy metabolism.计算机模拟和体外研究表明,白藜芦醇苷通过调节肝脏脂质-能量代谢,具有泛过氧化物酶体增殖物激活受体(PPAR)激动剂活性和抗非酒精性脂肪性肝病(NAFLD)的功效。
Sci Rep. 2025 Jul 24;15(1):26995. doi: 10.1038/s41598-025-12357-0.
2
Understanding the treatment of acute pancreatitis and its complications -a database for assessing traditional Chinese medicine use.了解急性胰腺炎及其并发症的治疗——一个用于评估中药使用情况的数据库。
Front Pharmacol. 2025 Jun 20;16:1583040. doi: 10.3389/fphar.2025.1583040. eCollection 2025.
3

本文引用的文献

1
Lingguizhugan Decoction, a Chinese herbal formula, improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease: a translational approach.灵龟护肝汤改善超重/肥胖非酒精性脂肪性肝病患者的胰岛素抵抗:转化医学方法。
Front Med. 2022 Oct;16(5):745-759. doi: 10.1007/s11684-021-0880-3. Epub 2022 Apr 26.
2
Curative effect of kangfuyan capsule combined with antibiotic treatment on pelvic inflammatory disease.抗妇炎胶囊联合抗生素治疗盆腔炎的疗效。
Pak J Pharm Sci. 2021 Nov;34(6 Spec):2479-2485.
3
Effectiveness and safety of Shugan Jianpi (SGJP) formula in the treatment of nonalcoholic steatohepatitis (NASH): A protocol for systematic review and meta-analysis of randomized controlled trials.
A pharmacoinformatic approach for studying DC's anticancer potential and control ROS-mediated apoptosis against prostate cancer cells.
一种用于研究树突状细胞(DC)抗癌潜力以及控制活性氧(ROS)介导的前列腺癌细胞凋亡的药物信息学方法。
Front Oncol. 2025 Feb 5;15:1471110. doi: 10.3389/fonc.2025.1471110. eCollection 2025.
4
The efficacy of traditional Chinese medicine sequential therapy in non-alcoholic fatty liver disease.中药序贯疗法在非酒精性脂肪性肝病中的疗效
Pak J Med Sci. 2025 Feb;41(2):512-518. doi: 10.12669/pjms.41.2.11352.
5
Comparative analysis of NAFLD-related health videos on TikTok: a cross-language study in the USA and China.TikTok上非酒精性脂肪性肝病相关健康视频的比较分析:美国和中国的跨语言研究
BMC Public Health. 2024 Dec 4;24(1):3375. doi: 10.1186/s12889-024-20851-9.
6
Traditional Chinese Medicine-based Treatment in Cardiovascular Disease: Potential Mechanisms of Action.基于中医药的心血管病治疗:作用机制探讨。
Curr Pharm Biotechnol. 2024;25(17):2186-2199. doi: 10.2174/0113892010279151240116103917.
7
Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies.中西医结合防治非酒精性脂肪性肝病:未来方向与策略
Chin Med. 2024 Feb 3;19(1):21. doi: 10.1186/s13020-024-00894-1.
8
Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids.祛瘀化浊汤通过调节肠道微生物群和血清脂质改善大鼠非酒精性脂肪肝。
Front Endocrinol (Lausanne). 2023 Oct 11;14:1272214. doi: 10.3389/fendo.2023.1272214. eCollection 2023.
9
Distinct common signatures of gut microbiota associated with damp-heat syndrome in patients with different chronic liver diseases.不同慢性肝病患者中与湿热证相关的肠道微生物群的独特共同特征。
Front Pharmacol. 2022 Nov 17;13:1027628. doi: 10.3389/fphar.2022.1027628. eCollection 2022.
疏肝健脾方治疗非酒精性脂肪性肝炎的有效性和安全性的系统评价和荟萃分析:随机对照试验的方案。
Medicine (Baltimore). 2021 Dec 23;100(51):e28366. doi: 10.1097/MD.0000000000028366.
4
The efficacy and safety of modified Gegenqinlian Fomular for advanced colorectal cancer (damp heat accumulation type): A multicenter randomized controlled trial.加味葛根芩连汤治疗晚期湿热蕴结型大肠癌的有效性和安全性:一项多中心随机对照试验。
Medicine (Baltimore). 2021 Dec 10;100(49):e27850. doi: 10.1097/MD.0000000000027850.
5
Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives.中医在非酒精性脂肪性肝病中的应用:分子机制与治疗前景
Chin Med. 2021 Aug 3;16(1):68. doi: 10.1186/s13020-021-00469-4.
6
The Distribution Pattern of Traditional Chinese Medicine Syndromes in 549 Patients with Type 2 Diabetes.549例2型糖尿病患者中医证候分布规律
Diabetes Metab Syndr Obes. 2021 May 17;14:2209-2216. doi: 10.2147/DMSO.S295351. eCollection 2021.
7
Alisol A 24-acetate stimulates lipolysis in 3 T3-L1 adipocytes.阿立醇 A24-醋酸酯可刺激 3T3-L1 脂肪细胞的脂解。
BMC Complement Med Ther. 2021 Apr 22;21(1):128. doi: 10.1186/s12906-021-03296-0.
8
Coix lacryma-jobi Seed Oil Reduces Fat Accumulation in Nonalcoholic Fatty Liver Disease by Inhibiting the Activation of the p-AMPK/SePP1/apoER2 Pathway.薏苡仁油通过抑制 p-AMPK/SePP1/apoER2 通路的激活减轻非酒精性脂肪性肝病中的脂肪堆积。
J Oleo Sci. 2021 May 1;70(5):685-696. doi: 10.5650/jos.ess20255. Epub 2021 Apr 12.
9
Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression.木瓜通过减轻氧化应激、炎症反应和脂肪生成基因表达来改善肥胖大鼠的非酒精性脂肪性肝病。
World J Hepatol. 2021 Mar 27;13(3):315-327. doi: 10.4254/wjh.v13.i3.315.
10
Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.四妙方通过调节肝脏脂质代谢和肠道微生物群来减轻非酒精性脂肪性肝病。
Phytomedicine. 2021 May;85:153544. doi: 10.1016/j.phymed.2021.153544. Epub 2021 Mar 10.